These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
165 related articles for article (PubMed ID: 16171287)
1. Analysis of hypocretin (orexin) antibodies in patients with narcolepsy. Black JL; Silber MH; Krahn LE; Fredrickson PA; Pankratz VS; Avula R; Walker DL; Slocumb NL Sleep; 2005 Apr; 28(4):427-31. PubMed ID: 16171287 [TBL] [Abstract][Full Text] [Related]
2. Studies of humoral immunity to preprohypocretin in human leukocyte antigen DQB1*0602-positive narcoleptic subjects with cataplexy. Black JL; Silber MH; Krahn LE; Avula RK; Walker DL; Pankratz VS; Fredrickson PA; Slocumb NL Biol Psychiatry; 2005 Sep; 58(6):504-9. PubMed ID: 16043129 [TBL] [Abstract][Full Text] [Related]
3. Hypocretin (orexin) levels in cerebrospinal fluid of patients with narcolepsy: relationship to cataplexy and HLA DQB1*0602 status. Krahn LE; Pankratz VS; Oliver L; Boeve BF; Silber MH Sleep; 2002 Nov; 25(7):733-6. PubMed ID: 12405608 [TBL] [Abstract][Full Text] [Related]
4. The role of cerebrospinal fluid hypocretin measurement in the diagnosis of narcolepsy and other hypersomnias. Mignot E; Lammers GJ; Ripley B; Okun M; Nevsimalova S; Overeem S; Vankova J; Black J; Harsh J; Bassetti C; Schrader H; Nishino S Arch Neurol; 2002 Oct; 59(10):1553-62. PubMed ID: 12374492 [TBL] [Abstract][Full Text] [Related]
6. Search for neuron-specific and nonneuron-specific antibodies in narcoleptic patients with and without HLA DQB1*0602. Black JL; Krahn LE; Pankratz VS; Silber M Sleep; 2002 Nov; 25(7):719-23. PubMed ID: 12405606 [TBL] [Abstract][Full Text] [Related]
7. Evaluation of hypothalamic-specific autoimmunity in patients with narcolepsy. Martínez-Rodríguez JE; Sabater L; Graus F; Iranzo A; Santamaria J Sleep; 2007 Jan; 30(1):27-8. PubMed ID: 17310861 [TBL] [Abstract][Full Text] [Related]
8. HLA DQB1*06:02 negative narcolepsy with hypocretin/orexin deficiency. Han F; Lin L; Schormair B; Pizza F; Plazzi G; Ollila HM; Nevsimalova S; Jennum P; Knudsen S; Winkelmann J; Coquillard C; Babrzadeh F; Strom TM; Wang C; Mindrinos M; Fernandez Vina M; Mignot E Sleep; 2014 Oct; 37(10):1601-8. PubMed ID: 25197808 [TBL] [Abstract][Full Text] [Related]
9. Ventilatory chemoresponsiveness, narcolepsy-cataplexy and human leukocyte antigen DQB1*0602 status. Han F; Mignot E; Wei YC; Dong SX; Li J; Lin L; An P; Wang LH; Wang JS; He MZ; Gao HY; Li M; Gao ZC; Strohl KP Eur Respir J; 2010 Sep; 36(3):577-83. PubMed ID: 20110394 [TBL] [Abstract][Full Text] [Related]
10. HLA-DQB1 allele and hypocretin in Korean narcoleptics with cataplexy. Jeong JH; Hong SC; Shin YK; Han JH; Lee SP J Korean Med Sci; 2007 Feb; 22(1):127-31. PubMed ID: 17297265 [TBL] [Abstract][Full Text] [Related]
11. [Positivity analysis of human leukocyte histocompatibility antigen-DQB1*0602 allele in Chinese patients with narcolepsy]. Li J; Dong X; Yan H; Liu Y; An P; Zhao L; Li Q; Zhang X; Gao Z; Han F Zhonghua Yi Xue Za Zhi; 2014 Mar; 94(10):763-5. PubMed ID: 24844961 [TBL] [Abstract][Full Text] [Related]
12. Traditional biomarkers in narcolepsy: experience of a Brazilian sleep centre. Coelho FM; Pradella-Hallinan M; Pedrazzoli M; Soares CA; Fernandes GB; Gonçalves AL; Tufik S; Bittencourt LR Arq Neuropsiquiatr; 2010 Oct; 68(5):712-5. PubMed ID: 21049180 [TBL] [Abstract][Full Text] [Related]
13. CD4+ T cell autoimmunity to hypocretin/orexin and cross-reactivity to a 2009 H1N1 influenza A epitope in narcolepsy. De la Herrán-Arita AK; Kornum BR; Mahlios J; Jiang W; Lin L; Hou T; Macaubas C; Einen M; Plazzi G; Crowe C; Newell EW; Davis MM; Mellins ED; Mignot E Sci Transl Med; 2013 Dec; 5(216):216ra176. PubMed ID: 24353159 [TBL] [Abstract][Full Text] [Related]
14. Symptomatic narcolepsy, cataplexy and hypersomnia, and their implications in the hypothalamic hypocretin/orexin system. Nishino S; Kanbayashi T Sleep Med Rev; 2005 Aug; 9(4):269-310. PubMed ID: 16006155 [TBL] [Abstract][Full Text] [Related]
16. Detection of autoantibodies against hypocretin, hcrtrl, and hcrtr2 in narcolepsy: anti-Hcrt system antibody in narcolepsy. Tanaka S; Honda Y; Inoue Y; Honda M Sleep; 2006 May; 29(5):633-8. PubMed ID: 16774153 [TBL] [Abstract][Full Text] [Related]
17. Screening the human prepro-orexin gene in a single-centre narcolepsy cohort. Quinnell TG; Farooqi IS; Smith IE; Shneerson JM Sleep Med; 2007 Aug; 8(5):498-502. PubMed ID: 17576097 [TBL] [Abstract][Full Text] [Related]
18. A/H1N1 antibodies and TRIB2 autoantibodies in narcolepsy patients diagnosed in conjunction with the Pandemrix vaccination campaign in Sweden 2009-2010. Lind A; Ramelius A; Olsson T; Arnheim-Dahlström L; Lamb F; Khademi M; Ambati A; Maeurer M; Nilsson AL; Bomfim IL; Fink K; Lernmark Å J Autoimmun; 2014 May; 50():99-106. PubMed ID: 24485154 [TBL] [Abstract][Full Text] [Related]
19. Elevated Tribbles homolog 2-specific antibody levels in narcolepsy patients. Cvetkovic-Lopes V; Bayer L; Dorsaz S; Maret S; Pradervand S; Dauvilliers Y; Lecendreux M; Lammers GJ; Donjacour CE; Du Pasquier RA; Pfister C; Petit B; Hor H; Mühlethaler M; Tafti M J Clin Invest; 2010 Mar; 120(3):713-9. PubMed ID: 20160349 [TBL] [Abstract][Full Text] [Related]
20. Hypocretin (orexin) biology and the pathophysiology of narcolepsy with cataplexy. Liblau RS; Vassalli A; Seifinejad A; Tafti M Lancet Neurol; 2015 Mar; 14(3):318-28. PubMed ID: 25728441 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]